Silverback Therapeutics Stock Price on February 1, 2025
| SPRY Stock | 10.79 0.06 0.55% |
Below is the normalized historical share price chart for Silverback Therapeutics extending back to December 04, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Silverback Therapeutics stands at 10.79, as last reported on the 9th of March, with the highest price reaching 11.55 and the lowest price hitting 10.76 during the day.
If you're considering investing in Silverback Stock, it is important to understand the factors that can impact its price. Silverback Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0929, which indicates the firm had a -0.0929 % return per unit of risk over the last 3 months. Silverback Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Silverback Therapeutics' Risk Adjusted Performance of (0.08), coefficient of variation of (855.02), and Variance of 11.32 to confirm the risk estimate we provide.
At this time, Silverback Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 115 M in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 136 M in 2025. . At this time, Silverback Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 2.14 in 2025, whereas Price Earnings Ratio is likely to drop (9.07) in 2025. Silverback Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of December 2020 | 200 Day MA 12.1211 | 50 Day MA 11.8366 | Beta 1.411 |
Silverback |
Sharpe Ratio = -0.0929
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SPRY |
Estimated Market Risk
| 3.16 actual daily | 28 72% of assets are more volatile |
Expected Return
| -0.29 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Silverback Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Silverback Therapeutics by adding Silverback Therapeutics to a well-diversified portfolio.
Price Book 5.2176 | Enterprise Value Ebitda (9.88) | Price Sales 410.6164 | Shares Float 46.5 M | Wall Street Target Price 29.8 |
Related Headline
Allarity Therapeutics Headline on 31st of January 2025
Allarity Therapeutics, Inc. Short Interest Update by thelincolnianonline.com
Allarity Therapeutics, Inc. saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 547,000 shares, an increase of 102.8 percent from the December 31st total of 269,700 shares. Approximately 13.8 percent of the shares of the company are sold short. Based
Silverback Therapeutics Valuation on February 1, 2025
It is possible to determine the worth of Silverback Therapeutics on a given historical date. On February 1, 2025 Silverback was worth 14.3 at the beginning of the trading date compared to the closed value of 13.02. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Silverback Therapeutics stock. Still, in general, we apply an absolute valuation method to find Silverback Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Silverback Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Silverback Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 14.45 | 14.87 | 14.07 | 14.29 | 872,591 | |
01/31/2025 | 14.30 | 14.58 | 12.75 | 13.02 | 2,023,133 |
| 12.63 | 12.76 | 11.89 | 12.31 | 2,168,769 |
| Backtest Silverback Therapeutics | | | Silverback Therapeutics History | | | Silverback Therapeutics Valuation | Previous | Next |
Silverback Therapeutics Trading Date Momentum on February 1, 2025
| On February 03 2025 Silverback Therapeutics was traded for 12.31 at the closing time. The top price for the day was 12.76 and the lowest listed price was 11.89 . The trading volume for the day was 2.2 M. The trading history from February 3, 2025 was a factor to the next trading day price decrease. The trading price change against the next closing price was 5.45% . The trading price change against the current closing price is 2.30% . |
Silverback Therapeutics Fundamentals Correlations and Trends
By evaluating Silverback Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Silverback Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Silverback financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Silverback Therapeutics Stock history
Silverback Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Silverback is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Silverback Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Silverback Therapeutics stock prices may prove useful in developing a viable investing in Silverback Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 109.5 M | 115 M | |
| Net Loss | -31.2 M | -29.7 M |
Silverback Therapeutics Quarterly Net Working Capital |
|
Silverback Therapeutics Stock Technical Analysis
Silverback Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Silverback Therapeutics Period Price Range
Low | March 9, 2025
| High |
0.00 | 0.00 |
Silverback Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Silverback Therapeutics March 9, 2025 Market Strength
Market strength indicators help investors to evaluate how Silverback Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Silverback Therapeutics shares will generate the highest return on investment. By undertsting and applying Silverback Therapeutics stock market strength indicators, traders can identify Silverback Therapeutics entry and exit signals to maximize returns
Silverback Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Silverback Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Silverback Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Silverback to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.08) | |||
| Treynor Ratio | (16.20) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Silverback Stock Analysis
When running Silverback Therapeutics' price analysis, check to measure Silverback Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silverback Therapeutics is operating at the current time. Most of Silverback Therapeutics' value examination focuses on studying past and present price action to predict the probability of Silverback Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silverback Therapeutics' price. Additionally, you may evaluate how the addition of Silverback Therapeutics to your portfolios can decrease your overall portfolio volatility.